flanders.bio's Healthcare Leaders Dinner

flanders.bio and KBC Securities will be organising - for the 4th time - an exclusive CEO Dinner with the listed Belgian biotech companies. During this high level dinner we will welcome the CEO’s of a select group of Belgian biopharma companies to openly discuss common topics that are important for our sector: financing of innovation, initiatives from and towards the government related to our sector, collaborations between all stakeholders involved, etc and to see where we can play a facilitating role.

The following CEO's confirmed their participation:

  • Edwin Moses, Ablynx
  • Tim Van Hauwermeiren, argenx
  • Herman Verrelst, Biocartis
  • Thomas Lienard, Bone Therapeutics
  • Christian Homsy, Celyad
  • Dirk Reyn, eTheRNA immunotherapies NV
  • Onno Van de Stolpe, Galapagos
  • Stef Heylen, Janssen Pharmaceutica
  • Jan Groen, MDxHealth
  • Francois Fornieri, Mithra
  • Patrik De Haes, ThromboGenics
  • Eduardo Bravo, TiGeniX

Event Details


Monday, December 11, 2017 (19:00 h - 22:00 h)


KBC Securities, Grote Markt, Brussel


FLANDERS.BIO MEMBER BENEFIT: This is an on-invitation-only event- exclusively for flanders.bio members



2017-12-11 19:00:00 2017-12-11 22:00:00 Europe/Brussels flanders.bio's Healthcare Leaders Dinner KBC Securities, Grote Markt, Brussel

More info?

For any further information about this event, please do not hesitate to get in touch with our Communications Coordinator

Alternate Text

Jonas De Backer

Communications Coordinator

| |

Interested in a regular update of the Life Sciences and biotech sector in Flanders?